{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NYR.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NYR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NYR.AU\",,,,,undefined,":{"symbol":"NYR.AU","market":"AU","secType":"STK","nameCN":"NYRADA INC-CDI","latestPrice":0.105,"timestamp":1745907120000,"preClose":0.1,"halted":0,"volume":114893,"delay":0,"nameEN":"NYRADA INC-CDI","floatShares":106311194,"shares":210333705,"eps":-0.021836,"marketStatus":"Closed","change":0.005,"latestTime":"04-29 16:12:00 AEST","open":0.105,"high":0.105,"low":0.1,"amount":11920,"amplitude":0.05,"askPrice":0.11,"askSize":47486,"bidPrice":0.1,"bidSize":179172,"shortable":3,"etf":0,"ttmEps":-0.021836,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745971200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.1,"openAndCloseTimeList":[[1745884800000,1745906400000]],"volumeRatio":0.78257,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NYR.AU\",,,,,undefined,":{"symbol":"NYR.AU","floatShares":106311194,"roa":"-45.16%","roe":"-76.35%","lyrEps":-0.008535,"volumeRatio":0.78257,"shares":210333705,"dividePrice":0,"high":0.105,"amplitude":0.05,"preClose":0.1,"low":0.1,"week52Low":0.032,"pbRate":"3.77","psRate":"13.39","week52High":0.155,"institutionHeld":0,"latestPrice":0.105,"committee":0.58099,"eps":-0.021836,"divideRate":0,"volume":114893,"delay":0,"ttmEps":-0.021836,"open":0.105,"prevYearClose":0.094,"prevWeekClose":0.1,"prevMonthClose":0.107,"prevQuarterClose":0.107,"fiveDayClose":0.11,"twentyDayClose":0.1,"sixtyDayClose":0.076},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NYR.AU\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NYR.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525062724","title":"ASX Market Close: Investors wipe $97B in biggest rout since COVID | April 7, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525062724","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525062724?lang=en_us&edition=fundamental","pubTime":"2025-04-07 14:59","pubTimestamp":1744009140,"startTime":"0","endTime":"0","summary":"The ASX200 closed down 4.2% at 7,343 points in a $97B wipeout for the market.The Energy sector was decimated, down 7%, followed by Financials, down 5%, and Materials and Discretionary – both down 4.8%.Lynas Rare News  closed up 3.1% after Aussie-listed miners of heavy rare earths rallied today, shrugging off major selloffs across other markets on bets Western governments would renew their push to develop a separate supply chain after top producer China set down export controls.Nyrada closed up 4.8% on reports of neuroprotective results for its lead drug candidate in a collaborative traumatic brain injury study with the Walter Reed Army Institute of Research and UNSW Sydney.Abacus Storage King  closed up 20.7% on news of an unsolicited takeover offer from a consortium, valuing the firm at around A$1.9 billion.Kelsian Groupfinished down 8.3% today despite developments in itsU.S.operations, where its wholly owned subsidiary, First Class Transportation, secured contract renewals and new bu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-investors-wipe-97b-in-biggest-rout-since-covid-april-7-2025-2025-04-07/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7067","KLS.AU","ASK.AU","BK7161","BK7095","BK7142","BK4211","BK7096","BK7151","BK7507","TLX.AU","ISBC","NYR.AU","LYC.AU","WDS.AU","BK7125"],"gpt_icon":0},{"id":"2525039449","title":"Study finds Nyrada’s lead drug can prevent secondary brain injury","url":"https://stock-news.laohu8.com/highlight/detail?id=2525039449","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525039449?lang=en_us&edition=fundamental","pubTime":"2025-04-07 08:24","pubTimestamp":1743985440,"startTime":"0","endTime":"0","summary":"Nyrada Inc  has reported strong results from a collaborative study into traumatic brain injury at the University of Sydney, in which its lead drug candidate NYR-BI03 showed neuroprotective effectiveness.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.Nyrada is working with the Walter Reed Army Institute of Research and the University of New South Wales on the project, which revealed that NYR-BI03 could prevent secondary brain injury following a penetrating traumatic brain injury.Chair of the Scientific Advisory Board  and UNSW Scientia Professor Gary Housley said these results were significant. “This study provides strong evidence that Nyrada’s NYR-BI03 drug protected the brain following severe TBI.”Nyrada shares have been trading at 9.3 cents.Join the discussion:See what HotCopperusers are saying aboutNyrada Inc. and be part of the conversations that move the markets.The material p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/study-finds-nyradas-lead-drug-can-prevent-secondary-brain-injury-2025-04-07/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["NYR.AU","BK7096"],"gpt_icon":0},{"id":"2525828086","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2525828086","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525828086?lang=en_us&edition=fundamental","pubTime":"2025-04-07 07:45","pubTimestamp":1743983104,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Nyrada (ASX:NYR)Nyrada's lead drug candidate, NYR-BI03, showed \"strong\" neuroprotecti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCF.AU","BK7031","BK7095","GBE.AU","HNG.AU","BK7096","DES.AU","AKN.AU","NYR.AU","BK7509"],"gpt_icon":0},{"id":"2523501049","title":"Nyrada Doses First Cohort in NYR-BI03's Phase I Human Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2523501049","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523501049?lang=en_us&edition=fundamental","pubTime":"2025-03-31 13:17","pubTimestamp":1743398272,"startTime":"0","endTime":"0","summary":"Nyrada Inc.  has dosed and discharged the first cohort of its Phase I human clinical trial of its lead drug candidate, NYR-BI03, according to a Monday filing with the Australian bourse.The primary endpoint of the trial is to assess the safety and tolerability of NYR-BI03 in healthy volunteers, when administered as a three-hour intravenous infusion, per the filing.Six participants received NYR-BI03, while two others received a placebo. Readouts from the trial are expected in the third quarter.NYR-BI03 is a small molecule, first-in-class neuroprotection, and cardioprotection treatment.Nyrada's shares were down 2% on market close.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","NYR.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NYR.AU\",params:#limit:5,,,undefined,":[{"date":"2023-07-28","symbol":"NYR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1690502400000,"name":null,"time":"","dateTimestamp":1690466400000,"actualEps":null},{"date":"2023-04-29","symbol":"NYR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1682726400000,"name":null,"time":"","dateTimestamp":1682690400000,"actualEps":null},{"market":"AU","date":"2022-08-29","symbol":"NYR.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1661695200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NYR.AU\",market:\"AU\",,,undefined,":[]}}